Related Experiment Video

Updated: Jul 15, 2026

Mechanism of Regulation of Adipocyte Numbers in Adult Organisms Through Differentiation and Apoptosis Homeostasis
08:34

Mechanism of Regulation of Adipocyte Numbers in Adult Organisms Through Differentiation and Apoptosis Homeostasis

Published on: June 3, 2016

HIF-1-regulated glucose metabolism: a key to apoptosis resistance?

Simone Fulda1, Klaus-Michael Debatin

  • 1University Children's Hospital, Ulm, Germany. simone.fulda@uniklinik-ulm.de

Cell Cycle (Georgetown, Tex.)
|April 4, 2007
PubMed

Insights

Cancer cells resist treatment partly due to hypoxia, a low-oxygen state. Targeting Hypoxia-Inducible Factor-1 alpha (HIF-1α) and its related genes may overcome this resistance, offering new cancer therapies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Cancer treatment resistance is a major clinical challenge.
  • Hypoxia, common in solid tumors, correlates with poor treatment outcomes.
  • Cancer cells adapt to hypoxia via signaling pathways that promote survival.

Purpose of the Study:

  • To identify molecular pathways driving cancer treatment resistance.
  • To investigate the role of Hypoxia-Inducible Factor-1 (HIF-1) in cancer adaptation to hypoxia.
  • To explore HIF-1alpha as a potential therapeutic target.

Main Methods:

  • Review of existing literature on cancer resistance and hypoxia.
  • Analysis of the role of HIF-1alpha in mediating cancer cell survival and growth.
  • Identification of hypoxia-inducible genes involved in cellular metabolism.

Main Results:

  • Hypoxia-Inducible Factor-1 (HIF-1), particularly its Hif-1alpha subunit, is crucial for cancer cell adaptation to low-oxygen environments.
  • Hif-1alpha activation promotes cancer cell survival and tumor growth by regulating genes involved in energy metabolism.
  • Hypoxia-inducible genes are upregulated in response to hypoxic conditions.

Conclusions:

  • Hif-1alpha plays a critical role in mediating cancer cell resistance to therapy.
  • Targeting Hif-1alpha and hypoxia-inducible genes presents a promising strategy for novel cancer therapeutics.
  • Pharmacological inhibition of these targets may offer new treatment options for various malignancies.

More Related Videos

High-resolution Respirometry to Measure Mitochondrial Function of Intact Beta Cells in the Presence of Natural Compounds12:32

High-resolution Respirometry to Measure Mitochondrial Function of Intact Beta Cells in the Presence of Natural Compounds

Published on: January 23, 2018

Live Images of GLUT4 Protein Trafficking in Mouse Primary Hypothalamic Neurons Using Deconvolution Microscopy08:47

Live Images of GLUT4 Protein Trafficking in Mouse Primary Hypothalamic Neurons Using Deconvolution Microscopy

Published on: December 7, 2017

Related Concept Videos

Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Glucose Homeostasis: Regulation of Blood Glucose01:02

Glucose Homeostasis: Regulation of Blood Glucose

Carbohydrates consumed through foods are converted into glucose, a crucial energy source for the body. In the prandial state, high blood glucose levels stimulate the secretion of insulin from the pancreas. Insulin inhibits hepatic glucose production and stimulates glucose uptake and metabolism by muscle and adipose tissue. The excess glucose is converted into glycogen and stored in the liver and muscles.
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but this inhibition is released...
Hormones Regulating Blood Glucose01:16

Hormones Regulating Blood Glucose

Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...